Skip to main content
. 2026 Feb 15;17(2):112867. doi: 10.4239/wjd.v17.i2.112867

Table 2.

Comparison of renal function between two groups of patients before and after treatment

Parameter
Time
CM group (n = 107)
CSCT group (n = 104)
t
P value
Serum creatinine (mg/dL) Baseline 1.04 ± 0.32 1.04 ± 0.29 0.122 0.903
6 months 1.05 ± 0.35 1.06 ± 0.31 0.265 0.791
GFR (mL/minute/1.73 m2) Baseline 50.83 ± 5.01 50.92 ± 5.19 0.126 0.900
6 months 50.13 ± 4.61 50.52 ± 4.87 0.603 0.547
ACR (mg/g) Baseline 211.51 ± 30.11 207.54 ± 30.15 0.956 0.340
6 months 158.11 ± 28.85 145.87 ± 29.23 3.062 0.002

GFR: Glomerular filtration rate; ACR: Albumin/creatinine ratio; CM: Canagliflozin monotherapy; CSCT: Canagliflozin and semaglutide combination therapy.